Today’s top gainers include the company Perrigo Company plc (NYSE:PRGO) which is in the industry Drug Related Products, gaining -1.71% today. In the last week its performance is 2.63%, and 9.27% for the past quarter. Currently, Perrigo Company plc, PRGO has a target price of 102.64, so today’s gain of -1.71% is a significant step towards its target price. The GAP today is therefore -0.77%.
Perrigo Company plc (NYSE:PRGO), has a market cap of 13716.19, and is based in Ireland. Insider ownership is at 0.10%, and institutional ownership is 75.10%.
At the current price of 95.73, it has a dividend yield of 0.61%, and its target price is 102.64. This is with a profit margin of -2.40%, and total debt/equity of 0.65. Perrigo Company plc (NYSE:PRGO) has a P/E of *TBA, as well as a forward P/E of 12.32.
With a current EPS of -0.95, and a forecasted EPS growth for next year at 10.13%,Perrigo Company plc (NYSE:PRGO) has had a EPS growth for the past five years at -59.80%. For the next five years EPS growth is projected to be 7.98%.
Performance for the year is -40.20%. Since its IPO date on 12/17/1991, the total performance to date is -33.56%.
Volume today for Perrigo Company plc (NYSE:PRGO), is 1017200, while its average volume is 2165.02. Whilst the total gain today was -1.71%, it did have a day high of -3.44%.
Volatility for this week has been at 2.12%, and 2.41% for the month. The 52-week low for Perrigo Company plc, PRGO has been 16.22%, while the 52-week-high has reached -43.64%.
Looking at its return of investments, which is 0.60%, and its return on assets is -0.70%. Perrigo Company plc (NYSE:PRGO) has an operating margin of 0.50%. With a sales growth of -3.30% quarter over quarter. Bearing in mind that Perrigo Company plc, PRGO is in the sector Healthcare, its long-term debt/equity is 0.57, and has a current ratio of 1.4 and 1 for quick ratio.
So what is the value of Perrigo Company plc? Well its PEG is *TBA, and the P/S is 2.43, along with a P/B of 1.38. Meanwhile it has a p/cash of *TBA.